About Us

TERAVOLT is a global consortium dedicated to the treatment of patients with thoracic malignancies who have come together to understand the impact of COVID-19 on our cancer patients. Our steering committee is made up of experts from the world’s leading medical research organizations.

Steering committee:

Marina Garrassino MD

Marina Garrassino MD
National Cancer Institute of Milan
Italy


Dr. Leora Horn

Dr. Leora Horn
Vanderbilt-Ingram Cancer Center
USA


Solange Peters, MD

Solange Peters
Lausanne University
Switzerland


Heather Wakelee

Heather Wakelee
Stanford University
USA


Fabrice Barlesi MD

Fabrice Barlesi MD
Institute Gustave Roussy
France


Anne-Marie Dingemans MD

Anne-Marie Dingemans MD
Maastrich University
Netherlands


Jan Van Meerbeeck MD

Jan Van Meerbeeck MD
Ghent University Hospital
Belgium


Jennifer Whisenant PhD

Jennifer Whisenant PhD
Vanderbilt Ingram Cancer Center
USA